Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SPP1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
SPP1 encodes osteopontin, a matricellular protein involved in neuroinflammation, cell survival, and neurodegenerative disease pathogenesis
| Gene Symbol | Secreted Phosphoprotein 1 (Osteopontin) |
| Chromosome | 4q21.1 |
| Function | encodes a secreted matricellular glycoprotein that functions as a cytokine, chemokine, and extracellular matrix protein. |
| Amino Acids | 314 aa |
| Pathways | Amyloid, Angiogenesis, Apoptosis, Complement, Immune Response |
| UniProt ID | P08421 |
| NCBI Gene ID | 6696 |
| Ensembl ID | ENSG00000118733 |
| OMIM | 166490 |
| Associated Diseases | AD, Als, Alzheimer, Alzheimer's disease, CCLM, Cancer |
| Known Drugs/Compounds | rapamycin, ursolic acid, amyloid-beta oligomers, BaP, Bap |
| Interactions | GRN, C1QA, CTSB, PTEN, GBM, STAT1 |
| SciDEX Hypotheses | Temporal SPP1 Inhibition During Critical Windows |
| KG Connections | 451 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
SPP1["SPP1/Osteopontin<br/>Matricellular Protein"] -->|"activates"| C1QA["C1QA/Complement"]
SPP1 -->|"activates"| Complement["Complement System"]
SPP1 -->|"activates"| GRN["GRN/Progranulin"]
SPP1 -->|"activates"| CTSB["CTSB"]
SPP1 -->|"activates"| Amyloid["Amyloid Pathology"]
SPP1 -->|"inhibits"| Angiogenesis["Angiogenesis"]
SPP1 -->|"expressed in"| Myeloid["Myeloid Cells"]
CHI3L1["CHI3L1"] -->|"regulates"| SPP1
GBM["GBM"] -->|"activates"| SPP1
ICAM1["ICAM1"] -->|"inhibits"| SPP1
MMP9["MMP9"] -->|"inhibits"| SPP1
SPP1 -->|"implicated in"| AD["Alzheimer's Disease"]
SPP1 -->|"implicated in"| ALS["ALS"]
SPP1 -->|"activates"| Dementia["Dementia"]
SPP1 -->|"regulates"| Glioblastoma["Glioblastoma"]
SPP1 -->|"therapeutic target"| Inflammation["Neuroinflammation"]
style SPP1 fill:#e74c3c,stroke:#c0392b,color:#e0e0e0
style C1QA fill:#3498db,stroke:#2980b9,color:#e0e0e0
style Complement fill:#3498db,stroke:#2980b9,color:#e0e0e0
style AD fill:#9b59b6,stroke:#8e44ad,color:#e0e0e0
style ALS fill:#9b59b6,stroke:#8e44ad,color:#e0e0e0
style Inflammation fill:#f39c12,stroke:#e67e22,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| SYNAPTIC ENGULFMENT | mediates | entity | 0.95 |
| ALZHEIMER'S DISEASE | implicated_in | entity | 0.95 |
| PHAGOCYTOSIS | regulates | entity | 0.95 |
| Microglial Phagocytic States | associated_with | process | 0.95 |
| Microglial Phagocytosis | activates | process | 0.95 |
| Microglial Phagocytosis | promotes | process | 0.95 |
| microglial phagocytosis | drives | process | 0.95 |
| Macrophage Inflammation | promotes | process | 0.95 |
| Lipid Dysregulation | promotes | phenotype | 0.95 |
| ALZHEIMER'S DISEASE | involved_in | disease | 0.95 |
| Synaptic Engulfment | mediates | process | 0.95 |
| Th17 cell differentiation | promotes | process | 0.95 |
| Atherosclerosis | contributes_to | disease | 0.95 |
| CD44 | binds_to | protein | 0.93 |
| microglial phagocytic state | associated_with | phenotype | 0.93 |
| ITGB1 | binds_to | protein | 0.93 |
| synaptic engulfment | promotes | process | 0.92 |
| Microglia | modulates | cell_type | 0.92 |
| ERK | activates | protein | 0.92 |
| C1Q | upregulates | entity | 0.90 |
| HIPPOCAMPUS | expressed_in | entity | 0.90 |
| Synaptic Loss | contributes_to | phenotype | 0.90 |
| C1QA | upregulates | gene | 0.90 |
| GRN | upregulates | gene | 0.90 |
| CTSB | upregulates | gene | 0.90 |
| macrophage inflammation | promotes | process | 0.90 |
| MICROGLIA | mediates | cell_type | 0.90 |
| Inflammation | promotes | process | 0.90 |
| microglia | induces | cell_type | 0.90 |
| PI3K/Akt/mTOR pathway | activates | pathway | 0.90 |
| idiopathic pulmonary fibrosis | causes | disease | 0.90 |
| NSCLC | causes | disease | 0.90 |
| Phagocytic Markers | upregulates | biomarker | 0.90 |
| Alzheimer's Disease | therapeutic_target | disease | 0.88 |
| Microglial Phagocytosis | upregulates | process | 0.88 |
| lipid dysregulation | mediates | phenotype | 0.85 |
| Macrophage Cytotoxicity | mediates | phenotype | 0.85 |
| Alzheimer'S Disease | involved_in | disease | 0.85 |
| foam cell phenotype | promotes | phenotype | 0.80 |
| Microglia | associated_with | cell_type | 0.80 |
| MICROGLIA | induces_phagocytic_states | cell_type | 0.80 |
| atherosclerosis | therapeutic_target | disease | 0.80 |
| phagocytic_state | induces | biological_process | 0.80 |
| ABCA1 | suppresses | gene | 0.75 |
| CD36 | upregulates | gene | 0.75 |
| PLIN2 | upregulates | gene | 0.75 |
| Senescence | activates | disease | 0.75 |
| RAGE | therapeutic_target | gene | 0.70 |
| MICROGLIA | associated_with | gene | 0.70 |
| microglia | expressed_in | cell_type | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PERIVASCULAR MACROPHAGES | expressed_in | entity | 0.95 |
| BaP | upregulates | compound | 0.95 |
| Bap | upregulates | compound | 0.95 |
| Mir-692 | inhibits | biomarker | 0.95 |
| ursolic acid | inhibits | drug | 0.91 |
| PERIVASCULAR FIBROBLASTS | expressed_in | entity | 0.90 |
| perivascular_cells | upregulates | cell_type | 0.90 |
| Perivascular Macrophages | upregulates | cell_type | 0.90 |
| Bap | binds | compound | 0.90 |
| Perivascular Fibroblasts | upregulates | cell_type | 0.85 |
| Perivascular Cells | expressed_in | cell_type | 0.85 |
| BaP | binds | compound | 0.85 |
| RPS18 | co_expressed_with | gene | 0.80 |
| MICROGLIA | induces | cell_type | 0.80 |
| amyloid-beta oligomers | modulates | compound | 0.80 |
| C1QA | regulates | entity | 0.60 |
| CTSB | regulates | entity | 0.60 |
| GRN | regulates | entity | 0.60 |
| CTSB | activates | gene | 0.60 |
| C1QA | activates | gene | 0.60 |
| CAMK4 | associated_with | gene | 0.60 |
| CD8 | associated_with | gene | 0.60 |
| RB1 | therapeutic_target | gene | 0.60 |
| CHI3L1 | regulates | gene | 0.60 |
| GBM | activates | gene | 0.60 |
| STAT3 | regulates | gene | 0.60 |
| RAGE | therapeutic_target | gene | 0.60 |
| SERPINE1 | inhibits | gene | 0.60 |
| NOS2 | inhibits | gene | 0.60 |
| MMP2 | inhibits | gene | 0.60 |
| PTGS2 | inhibits | gene | 0.60 |
| KDR | inhibits | gene | 0.60 |
| MMP9 | inhibits | gene | 0.60 |
| ICAM1 | inhibits | gene | 0.60 |
| GRN | activates | gene | 0.60 |
| CAMK4 | therapeutic_target | gene | 0.60 |
| CD8 | therapeutic_target | gene | 0.60 |
| MMP3 | associated_with | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| CD4 | regulates | gene | 0.60 |
| CD44 | regulates | gene | 0.60 |
| TREM2 | activates | gene | 0.60 |
| CD8 | activates | gene | 0.60 |
| HMOX1 | associated_with | gene | 0.60 |
| IGF1 | associated_with | gene | 0.60 |
| KIF20A | associated_with | gene | 0.60 |
| MCC | therapeutic_target | gene | 0.60 |
| SLC7A11 | associated_with | gene | 0.60 |
| YBX1 | activates | gene | 0.60 |
| ANXA2 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Temporal SPP1 Inhibition During Critical Windows | 0.650 | neuroinflammation | What molecular mechanisms mediate SPP1-i |
Scientific analyses that reference this entity
neuroinflammation | 2026-04-15 | 1 hypotheses Top: 0.650
synaptic biology | 2026-04-07 | 0 hypotheses
neurodegeneration | 2026-04-06 | 0 hypotheses
neuroinflammation | 2026-04-06 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| SPP1-mediated microglial synaptic engulfment assay | exploratory | Alzheimer's disease | 0.950 | 0.00 | AD mouse models with amyloid-β | proposed | N/A |
| SPP1 upregulation in perivascular cells in AD mouse models | exploratory | Alzheimer's disease | 0.900 | 0.00 | AD mouse models | proposed | N/A |
| Single-cell RNA sequencing of microglial states in AD hippocampus | exploratory | Alzheimer's disease | 0.850 | 0.00 | AD mouse hippocampus | proposed | N/A |
| Cell-cell interaction analysis of perivascular-microglial crosstalk | exploratory | Alzheimer's disease | 0.800 | 0.00 | AD mouse models | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||